STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 69 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $289,000 | +20.9% | 26,000 | 0.0% | 0.35% | +27.0% |
| Q2 2017 | $239,000 | +7.7% | 26,000 | 0.0% | 0.28% | +14.4% |
| Q1 2017 | $222,000 | -20.1% | 26,000 | 0.0% | 0.24% | -18.2% |
| Q4 2016 | $278,000 | +4.1% | 26,000 | 0.0% | 0.30% | +17.4% |
| Q3 2016 | $267,000 | +50.0% | 26,000 | -1.2% | 0.25% | +51.5% |
| Q2 2016 | $178,000 | +63.3% | 26,305 | +12.9% | 0.17% | +67.0% |
| Q1 2016 | $109,000 | -6.0% | 23,305 | +27.3% | 0.10% | +9.9% |
| Q4 2015 | $116,000 | -41.4% | 18,305 | +9.0% | 0.09% | -32.6% |
| Q2 2015 | $198,000 | +7.0% | 16,796 | +31.3% | 0.14% | -2.2% |
| Q1 2015 | $185,000 | -26.6% | 12,796 | -13.5% | 0.14% | +1.5% |
| Q4 2014 | $252,000 | -9.0% | 14,796 | -33.3% | 0.14% | -8.7% |
| Q3 2014 | $277,000 | +30.0% | 22,196 | +53.1% | 0.15% | +40.6% |
| Q2 2014 | $213,000 | -10.1% | 14,500 | +19.8% | 0.11% | -17.8% |
| Q4 2013 | $237,000 | – | 12,100 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
| VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
| Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
| CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
| SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
| Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
| J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
| BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
| Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |